The cells arent absorbing enough sugar
The clinical trial evidence indicates that tirzepatide is associated with better glycemic control and weight reduction than the conventional GLP-1 monotherapy, with the SURPASS clinical trial program being associated with HbA1c changes of up to 2.4% compared to baseline and weight reduction of more than 22% of the baseline weight at the highest dosage
The risk of injecting degraded tirzepatide includes reduced efficacy (it simply does not work) and potential injection site reactions or other adverse effects from degraded protein fragments
Por supuesto que la que te podemos recomendar es esta ltima, ya que es la que emplean aquellas personas que practican deportes de resistencia, o pasan mucho tiempo entrenando
Behnoush et al
Khatoon R, Ghani M, Shahzad S, Siddiqa M, Azmat M, Zafar I, Shafiq S